Cargando…
Sorafenib controls the epithelial-mesenchymal transition of ovarian cancer cells via EGF and the CD44-HA signaling pathway in a cell type-dependent manner
Cluster of differentiation (CD) 44 and epidermal growth factor (EGF) are closely involved in cellular migration and have been used as stem cell markers. Although the hyaluronan (HA)-binding CD44 is responsible for enhanced cellular motility, the mechanism underlying its actions in various cell types...
Autores principales: | Park, Ga Bin, Ko, Hyun-Suk, Kim, Daejin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561797/ https://www.ncbi.nlm.nih.gov/pubmed/28627617 http://dx.doi.org/10.3892/mmr.2017.6773 |
Ejemplares similares
-
MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
por: Vos, Maria Caroline, et al.
Publicado: (2016) -
Morphological State Transition Dynamics in EGF-Induced Epithelial to Mesenchymal Transition
por: Devaraj, Vimalathithan, et al.
Publicado: (2019) -
Sorafenib inhibits ovarian cancer cell proliferation and mobility and induces radiosensitivity by targeting the tumor cell epithelial–mesenchymal transition
por: Tian, Chuntao, et al.
Publicado: (2022) -
Inhibitory effects of metformin at low concentration on epithelial–mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells
por: Zhang, Rongrong, et al.
Publicado: (2015) -
The role of CD44 in epithelial–mesenchymal transition and cancer development
por: Xu, Hanxiao, et al.
Publicado: (2015)